-
Table 1 describes the baseline characteristics of the adults stratified by napping duration. A total of 13,706 participants (6,676 men and 7,030 women, 49.5 ± 11.3 years old) were involved, with 1,526 CVD, 1,098 HTN, and 413 stroke incidents during the 97,415.82 person-years of follow-up (median follow-up, 6.1 years). The proportions of the population with napping duration of < 30, 30 to 60, and ≥ 60 min were 9.4%, 24.7%, and 15.6%, respectively. More than half of the participants lived in rural communities (56.8%) and were from the northern regions (59.2%). The participants had an average of 6.7 years of academic education, wherein > 20% were illiterate. Approximately 75.6% of adults responded “no” to participating in any physical activity, and over three-fifths were never-smokers (60.9%) and never-drinkers (77.2%). As regards nighttime sleep, participants who reported a sleep duration of < 6 h and ≥ 8 h per night accounted for 18.5% and 25.4%, respectively.
Table 1. Baseline characteristics of included participants (n = 13,706) by daytime napping
Items Total Nap duration 0 min < 30 min 30 to 60 min ≥ 60 min Population Persons, n 13,706 6,884 1,292 3,383 2,147 Incident CVD, n 1,526 665 147 428 286 Incident HTN, n 1,098 474 97 307 220 Incident stroke, n 413 183 31 132 67 Individual covariates Male, % 48.7 47.7 43.0 50.1 53.1 Age, years 49.5 ± 11.3 49.0 ± 11.3 48.4 ± 11.1 49.9 ± 11.3 50.1 ± 11.5 BMI, kg/m2 22.9 ± 3.3 22.4 ± 3.2 23.0 ± 3.3 22.9 ± 3.3 23.1 ± 3.3 Han ethnicity, % 93.5 91.3 95.6 95.3 95.9 Married, % 93.3 92.8 93.0 93.7 92.9 Urban, % 43.2 43.1 51.1 44.5 36.4 North, % 59.2 51.2 63.5 65.0 73.5 Educational attainment, % Illiteracy 22.4 25.4 15.8 19.0 21.8 1–6 years 26.3 26.2 22.1 26.3 29.0 7–12 years 46.1 44.6 52.6 48.2 46.4 > 12 years 5.2 3.8 9.5 6.5 2.7 Employment status, % Current 55.3 55.0 59.8 53.7 56.1 Former 28.6 27.8 27.3 30.9 28.3 Never 16.1 17.2 12.8 15.5 15.6 Annual household income, % Low 28.8 30.6 23.8 27.1 28.9 Medium 43.4 42.1 45.0 43.6 46.0 High 27.8 27.3 31.2 29.4 25.1 Physical activity, % 0 min/week 75.6 80.2 64.2 70.9 75.1 1–150 min/week 23.9 19.4 34.9 28.6 24.1 > 150 min/week 0.5 0.4 0.9 0.5 0.8 Smoking status, % Yes 39.0 38.1 33.9 39.5 44.8 No 60.9 61.9 66.1 60.5 55.2 Alcohol consumption, % Yes 22.8 21.3 21.5 23.4 27.4 No 77.2 78.7 78.6 76.6 72.7 Sleep duration, % < 6 hours/night 18.5 12.0 12.9 20.0 40.0 6 to 8 hours/night 56.1 57.3 59.2 59.4 45.0 ≥ 8 hours/night 25.4 30.8 27.9 20.6 15.0 Note. Data are presented using mean ± SD for continuous variables and percentages for categorical variables. BMI, body mass index; CVD, cardiovascular disease; HTN, hypertension. -
Table 2 outlines the crude and adjusted HRs for the associations between daytime napping and CVD and HTN. Compared with non-nappers, both crude and multivariate models revealed higher risks of incident CVD and HTN in nappers ≥ 30 min and a greater risk of stroke in medium nappers (30–60 min), while no significant associations were found in short nappers (0–30 min). The trend analysis of nap-CVD associations demonstrated significantly elevated incident risks with napping duration. For instance, incident risks increased respectively by 22% (1.22, 1.08–1.39) for CVD and 21% (1.21, 1.04–1.41) for HTN in 30 to < 60 min nappers, with corresponding HRs of 1.27 (1.09–1.47) and 1.38 (1.16–1.65) among nappers ≥ 60 min.
Table 2. Effects of daytime napping on cardiovascular disease
Diseases Groups Age- and gender-adjusted model Multivariate modela HR (95% CI) P value P for trend HR (95% CI) P value P for trend CVD < 0.001 < 0.001 0 min 1 (Ref) 1 (Ref) < 30 min 1.17 (0.98 to 1.40) 0.087 1.07 (0.89 to 1.29) 0.448 30 to 60 min 1.29 (1.14 to 1.46) < 0.001 1.22 (1.08 to 1.39) 0.002 ≥ 60 min 1.36 (1.18 to 1.57) < 0.001 1.27 (1.09 to 1.47) 0.002 HTN < 0.001 < 0.001 0 min 1 (Ref) 1 (Ref) < 30 min 1.12 (0.90 to 1.40) 0.308 1.04 (0.83 to 1.30) 0.752 30 to 60 min 1.29 (1.12 to 1.50) 0.001 1.21 (1.04 to 1.41) 0.012 ≥ 60 min 1.48 (1.25 to 1.75) < 0.001 1.38 (1.16 to 1.65) < 0.001 Stroke 0.140 0.137 0 min 1 (Ref) 1 (Ref) < 30 min 0.89 (0.61 to 1.30) 0.544 0.96 (0.65 to 1.42) 0.845 30 to 60 min 1.39 (1.11 to 1.75) 0.004 1.39 (1.10 to 1.76) 0.006 ≥ 60 min 1.07 (0.80 to 1.43) 0.625 1.04 (0.77 to 1.40) 0.602 Note. aWe adjusted gender, age, BMI, ethnicity, marital status, residential region, geolocation, educational attainment, employment status, annual household income, physical activity, smoking status, alcohol consumption, and sleep duration. HR, hazard ratio; 95% CI, 95% confidence interval. -
Table 3 and Table 4 summarize subgroup-specific estimates for associations of CVD and HTN risks with daytime napping. Overall, evident nap-incidence associations were consistently observed in 30+ min nappers, while nap-associated risks tended to be more profound among nappers with > 1 h/day. Significant trends for greater risks of CVD and HTN associated with longer naps were observed in all strata except for urban dwellers, south, and active physical exercise (Ptrend
> 0.05). Stratified analyses for stroke incidence are presented in Supplementary Table S1 (available in www.besjournal.com), where in associations with medium midday napping existed in female, older participants, underweight adults (BMI < 24 kg/m2), rural and north residents, smokers, non-drinkers, and long sleepers. Table 3. Subgroup analysis for the association of nap duration with cardiovascular disease
Subgroup Hazard ratioa (95% CI) P for trend P for interaction < 30 min 30 to 60 min ≥ 60 min Gender 0.640 Male (n = 6,676) 1.03 (0.75 to 1.41) 1.20 (0.98 to 1.46) 1.38 (1.11 to 1.73)** 0.003 Female (n = 7,030) 1.09 (0.87 to 1.37) 1.25 (1.06 to 1.48)** 1.21 (0.98 to 1.49) 0.010 Age, years 0.539 30–49 (n = 7,411) 1.11 (0.80 to 1.55) 1.36 (1.08 to 1.73)** 1.23 (0.91 to 1.65) 0.028 ≥ 50 (n = 6,295) 1.08 (0.86 to 1.35) 1.17 (1.01 to 1.37)* 1.31 (1.10 to 1.56)** 0.001 BMI, kg/m² 0.382 < 24 (n = 9,449) 1.22 (0.96 to 1.57) 1.30 (1.10 to 1.54)** 1.32 (1.08 to 1.62)** 0.001 ≥ 24 (n = 4,257) 0.97 (0.74 to 1.29) 1.15 (0.95 to 1.40) 1.24 (0.99 to 1.55) 0.036 Residential region 0.191 Urban (n = 5,914) 1.00 (0.78 to 1.29) 1.08 (0.90 to 1.30) 1.09 (0.87 to 1.38) 0.344 Rural (n = 7,792) 1.17 (0.89 to 1.53) 1.34 (1.12 to 1.60)** 1.41 (1.15 to 1.72)** < 0.001 Geolocation 0.043 North (n = 8,120) 1.06 (0.84 to 1.34) 1.30 (1.11 to 1.53)** 1.33 (1.11 to 1.60)** < 0.001 South (n = 5,586) 1.11 (0.81 to 1.51) 1.09 (0.88 to 1.35) 1.14 (0.86 to 1.51) 0.283 Physical activity 0.189 Yes (n = 3,345) 1.10 (0.82 to 1.46) 1.11 (0.89 to 1.39) 1.01 (0.76 to 1.34) 0.642 No (n = 10,361) 1.03 (0.80 to 1.32) 1.26 (1.07 to 1.47)** 1.38 (1.16 to 1.65)*** < 0.001 Smoking status 0.790 Yes (n = 5,356) 1.02 (0.71 to 1.46) 1.34 (1.08 to 1.67)* 1.42 (1.12 to 1.81)** 0.001 No (n = 8,350) 1.10 (0.89 to 1.37) 1.18 (1.01 to 1.38)* 1.20 (0.99 to 1.46) 0.020 Alcohol consumption 0.007 Yes (n = 3,121) 1.29 (0.86 to 1.92) 1.11 (0.83 to 1.47) 1.46 (1.08 to 1.97)* 0.031 No (n = 10,585) 1.02 (0.83 to 1.26) 1.26 (1.09 to 1.45)** 1.18 (0.99 to 1.43) 0.001 Sleep duration, hours/night 0.168 < 7 (n = 5,599) 0.96 (0.69 to 1.33) 1.17 (0.96 to 1.42) 1.22 (0.97 to 1.52) 0.357 ≥ 7 (n = 8,072) 1.13 (0.90 to 1.42) 1.30 (1.09 to 1.55)** 1.30 (1.05 to 1.61)** 0.001 Note. aWe adjusted gender, age, BMI, ethnicity, marital status, residential region, educational attainment, employment status, annual household income, physical activity, smo, king status, alcohol consumption, and sleep duration. 95% CI, 95% confidence interval. *P < 0.05; **P < 0.01; ***P < 0.001. Table 4. Subgroup analysis for the association of nap duration with hypertension
Subgroup Hazard ratioa (95% CI) P for trend P for interaction < 30 min 30 to < 60 min ≥ 60 min Gender 0.670 Male (n = 6,676) 0.87 (0.60 to 1.28) 1.18 (0.94 to 1.48) 1.42 (1.11 to 1.83)*** 0.006 Female (n =7,030) 1.12 (0.84 to 1.49) 1.24 (1.01 to 1.52)** 1.36 (1.06 to 1.73)** 0.006 Age, years 0.092 30–49 (n = 7,411) 1.13 (0.76 to 1.69) 1.45 (1.09 to 1.92)*** 1.46 (1.03 to 2.05)** 0.006 ≥ 50 (n = 6,295) 1.01 (0.77 to 1.33) 1.13 (0.95 to 1.35) 1.38 (1.13 to 1.69)*** 0.003 BMI, kg/m² 0.396 < 24 (n = 9,449) 1.18 (0.87 to 1.61) 1.26 (1.02 to 1.55)** 1.46 (1.14 to 1.85)*** 0.001 ≥ 24 (n = 4,257) 0.95 (0.68 to 1.31) 1.20 (0.97 to 1.50) 1.38 (1.07 to 1.77)** 0.008 Residential region 0.244 Urban (n = 5,914) 1.08 (0.80 to 1.44) 1.06 (0.85 to 1.31) 1.20 (0.92 to 1.57) 0.230 Rural (n = 7,792) 0.97 (0.68 to 1.39) 1.37 (1.10 to 169)*** 1.52 (1.20 to 1.92)**** < 0.001 Geolocation 0.027 North (n = 8,120) 1.10 (0.82 to 1.47) 1.36 (1.11 to 1.66)*** 1.58 (1.26 to 1.97)**** < 0.001 South (n = 5,586) 1.99 (0.69 to 1.41) 1.08 (0.85 to 1.36) 1.15 (0.84 to 1.55) 0.351 Physical activity 0.040 Yes (n = 3,345) 1.14 (0.82 to 1.58) 1.06 (0.81 to 1.38) 1.01 (0.73 to 1.41) 0.824 No (n=10,361) 0.91 (0.66 to 1.24) 1.27 (1.06 to 1.53)** 1.57 (1.28 to 1.93)**** < 0.001 Smoking status 0.538 Yes (n = 5,356) 0.84 (0.53 to 1.33) 1.34 (1.04 to 1.73)** 1.50 (1.14 to 1.99)*** 0.002 No (n = 8,350) 1.11 (0.86 to 1.44) 1.15 (0.95 to 1.39) 1.32 (1.05 to 1.65)** 0.015 Alcohol consumption 0.272 Yes (n = 3,121) 1.25 (0.78 to 2.01) 1.23 (0.89 to 1.70) 1.56 (1.11 to 2.20)** 0.016 No (n = 10,585) 0.98 (0.76 to 1.27) 1.21 (1.02 to 1.43)** 1.34 (1.09 to 1.64)*** 0.004 Sleep duration, hours/night 0.370 < 7 (n = 5,599) 0.86 (0.57 to 1.29) 1.13 (0.90 to 1.43) 1.34 (1.04 to 1.72)** 0.023 ≥ 7 (n = 8,072) 1.11 (0.85 to 1.46) 1.31 (1.06 to 1.62)** 1.41 (1.10 to 1.79)*** 0.001 Note. aWe adjusted gender, age, BMI, ethnicity, marital status, residential region, educational attainment, employment status, annual household income, physical activity, smoking status, alcohol consumption, and sleep duration. 95% CI, 95% confidence interval. *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001. In gender-specific associations, both men and women exhibited increased risks with longer napping duration (Ptrend < 0.02). Generally, larger risks were identified in adults aged 30–49 years, particularly for HTN, with a p value for interaction of 0.092. Higher nap-associated risks mainly existed in participants with lower BMI (< 24 kg/m2), except for HTN in 60+ min nappers. We found some evidence of regional differences in nap-CVD associations, where increased risks occurred in rural and northern residents only. Specifically, significant effect modification by geolocation (north China versus south China) was identified for total CVD (P = 0.043) and HTN (P = 0.027).
Our results also highlighted that the nap-CVD association was modified by physical activity, with larger incident risks found among physically inactive adults. Smokers and alcohol drinkers were observed to have higher CVD risks induced by longer napping. Specifically, the incidence of CVD and HTN remarkably increased among smokers with 30+ min naps, while risks elevated significantly only in drinkers who napped ≥ 60 min. Moreover, associations of long napping duration with CVDs appear to be more evident among adults who had longer nocturnal sleep. For instance, 30–60 min of napping resulted in 30% (9%–55%) and 31% (6%–62%) higher risks of CVD and HTN in adults who slept ≥ 7 h/night, respectively, corresponding to insignificant HRs of 1.17 (0.96–1.42) and 1.13 (0.90–1.43) in those slept < 7 h/night.
Sensitivity analyses (Supplementary Table S2 available in www.besjournal.com) demonstrated the robustness of our main findings that nap ≥ 30 min was associated with an increased risk of CVD events. In terms of total CVD outcome in relation to napping duration of 30 to < 60 min, the risk estimates kept unchanged when we excluded CVD cases diagnosed in the initial first year after the baseline study or excluded those aged > 75 years, with HRs ranging from 1.22 (1.08, 1.39) to 1.23 (1.09, 1.40) (model 1) and 1.25 (1.10, 1.42) (model 2), respectively. The estimated HRs slightly increased when restricting our analysis to participants without changes in daytime-napping behaviors, while our main findings remained [HR = 1.38 (1.20, 1.57), model 3].
Table S2. Sensitive analysis of hazard ratios (95% CIs) for incident CVDs associated with napping duration, by excluding those who developed outcomes in 1 year after baseline survey, study participants aged > 75 years and participants who had changed daytime-napping behaviors during follow-ups
Diseases Groups HR (95% CI) Main model Model 1 Model 2 Model 3 CVD < 30 min 1.07 (0.89, 1.29) 1.10 (0.92, 1.33) 1.10 (0.91, 1.33) 1.25 (1.03, 1.51)* 30 to 60 min 1.22 (1.08, 1.39)** 1.23 (1.09, 1.40)** 1.25 (1.10, 1.42)** 1.38 (1.20, 1.57)*** ≥ 60 min 1.27 (1.09, 1.47)** 1.28 (1.11, 1.48)*** 1.33 (1.15, 1.54)*** 1.42 (1.22, 1.66)*** HTN < 30 min 1.04 (0.83, 1.30) 1.04 (0.83, 1.30) 1.05 (0.84, 1.31) 1.14 (0.90, 1.45) 30 to 60 min 1.21 (1.04, 1.41)* 1.22 (1.05, 1.42)** 1.23 (1.06, 1.44)** 1.36 (1.16, 1.60)*** ≥ 60 min 1.38 (1.16, 1.65)*** 1.41 (1.19, 1.67)*** 1.44 (1.12, 1.71)*** 1.57 (1.31, 1.88)*** Stroke < 30 min 0.96 (0.65, 1.42) 1.01 (0.69, 1.49) 1.04 (0.71, 1.54) 1.06 (0.70, 1.59) 30 to 60 min 1.39 (1.10, 1.76)** 1.40 (1.11, 1.77)** 1.43 (1.13, 1.81)** 1.52 (1.19, 1.95)*** ≥ 60 min 1.04 (0.77, 1.40) 1.06 (0.79, 1.42) 1.09 (0.81, 1.47) 1.14 (0.84, 1.55) Note. Abbreviations: HR, hazard ratio; CI, confidence interval; CVDs, cardiovascular diseases; HTN, hypertension. Model 1: restricting our study outcomes beyond the initial first year. Model 2: restricting participants aged < 75 years. Model 3: restricting the analysis to adults who had not changed daytime-napping behaviors during follow-ups. *P < 0.05, **P < 0.01, ***P < 0.001. -
The authors declare they have no conflicts of interest.
Table S1. Subgroup analysis for the association of nap duration with stroke
Subgroup Hazard ratioa (95% CI) P for trend P for interaction < 30 min 30 to 60 min ≥ 60 min Gender 0.339 Male (n = 6,676) 0.81 (0.42 to 1.58) 1.36 (0.96 to 1.91) 1.17 (0.78 to 1.75) 0.183 Female (n = 7,030) 1.08 (0.67 to 1.75) 1.39 (1.01 to 1.93)* 0.86 (0.54 to 1.37) 0.549 Age, years 0.815 30–49 (n = 7,411) 0.67 (0.26 to 1.71) 1.20 (0.70 to 2.04) 0.75 (0.36 to 1.54) 0.810 ≥ 50 (n = 6,295) 1.07 (0.70 to 1.64) 1.43 (1.10 to 1.86)** 1.13 (0.81 to 1.58) 0.077 BMI, kg/m2 0.464 < 24 (n = 9,449) 0.71 (0.41 to 1.22) 1.39 (1.06 to 1.84)* 0.91 (0.63 to 1.33) 0.417 ≥ 24 (n = 4,257) 1.47 (0.82 to 2.61) 1.30 (0.84 to 2.02) 1.30 (0.77 to 2.19) 0.227 Residential region 0.351 Urban (n = 5,914) 0.88 (0.49 to 1.57) 1.18 (0.81 to 1.73) 0.99 (0.59 to 1.67) 0.653 Rural (n = 7,792) 1.05 (0.62 to 1.77) 1.59 (1.17 to 2.16)** 1.09 (0.75 to 1.59) 0.108 Geolocation < 0.001 North (n = 8,120) 0.94 (0.60 to 1.46) 1.32 (1.00 to 1.74)* 0.89 (0.63 to 1.26) 0.695 South (n = 5,586) 0.95 (0.43 to 2.13) 1.33 (0.84 to 2.13) 1.44 (0.78 to 2.65) 0.139 Physical activity 0.787 Yes (n = 3,345) 0.84 (0.42 to 1.69) 1.51 (0.98 to 2.33) 0.81 (0.42 to 1.53) 0.570 No (n = 10,361) 1.07 (0.67 to 1.71) 1.31 (0.98 to 1.73) 1.08 (0.77 to 1.52) 0.240 Smoking status 0.380 Yes (n = 5,356) 0.73 (0.33 to 1.61) 1.61 (1.11 to 2.34)* 1.19 (0.76 to 1.86) 0.104 No (n = 8,350) 1.08 (0.69 to 1.69) 1.29 (0.95 to 1.75) 0.91 (0.60 to 1.38) 0.602 Alcohol consumption 0.751 Yes (n = 3,121) 0.69 (0.24 to 1.97) 1.31 (0.79 to 2.17) 1.12 (0.64 to 1.99) 0.449 No (n = 10,585) 1.04 (0.68 to 1.58) 1.43 (1.10 to 1.86)** 1.02 (0.71 to 1.45) 0.165 Sleep duration, hours/night 0.364 < 7 (n = 5,599) 0.70 (0.36 to 1.37) 0.97 (0.69 to 1.37) 0.84 (0.55 to 1.26) 0.528 ≥ 7 (n = 8,072) 1.12 (0.69 to 1.80) 1.86 (1.35 to 2.57)*** 1.20 (0.78 to 1.86) 0.012 Note. aWe adjusted gender, age, BMI, ethnicity, marital status, residential region, educational attainment, employment status, annual household income, physical activity, smoking status, alcohol consumption, and sleep duration. 95% CI, 95% confidence interval. *P < 0.05; **P < 0.01; ***P < 0.001.
doi: 10.3967/bes2022.004
Associations of Daytime Napping with Incident Cardiovascular Diseases and Hypertension in Chinese Adults: A Nationwide Cohort Study
-
Abstract:
Objective This study aimed to examine the associations of daytime napping with incident risks of cardiovascular diseases (CVDs) and hypertension (HTN). Methods Data for napping and CVD outcomes in 25 provinces were collected from baseline (2010) and three waves of follow-up (2012–2017) investigations of the China Family Panel Studies. Cox frailty models with random intercepts for the surveyed provinces were used to assess the longitudinal effects of daytime napping on CVD and HTN. Results Compared with non-nappers, 30+ min nappers had higher risks of CVD and HTN, while no significant associations were observed among < 30 min nappers. Incident risks among 30- to < 60-min nappers increased by 22% [hazard ratio (HR) 1.22, 95% confidence interval (CI) 1.08–1.39] for CVD and 21% (1.21, 1.04–1.41) for HTN, respectively, with corresponding HRs of CVD and HTN of 1.27 (1.09–1.47) and 1.38 (1.16–1.65) among ≥ 60 min nappers. Nap-associated CVD risks varied by subgroups, with stronger associations in participants with lower body mass index (< 24 kg/m2), physically inactive persons, smokers, and participants with longer nighttime sleep (≥ 7 h/night). Significant effects of daytime napping were observed on rural and northern residents only, highlighting great regional variations in CVD risks associated with napping habits. Conclusions This cohort study revealed strong evidence that long daytime napping (≥ 30 min) is associated with an increased incidence of cardiovascular events. -
Key words:
-
Daytime napping / - Cardiovascular disease /
- Hypertension /
- Adults /
- Sleep duration
注释: -
-
Table 1. Baseline characteristics of included participants (n = 13,706) by daytime napping
Items Total Nap duration 0 min < 30 min 30 to 60 min ≥ 60 min Population Persons, n 13,706 6,884 1,292 3,383 2,147 Incident CVD, n 1,526 665 147 428 286 Incident HTN, n 1,098 474 97 307 220 Incident stroke, n 413 183 31 132 67 Individual covariates Male, % 48.7 47.7 43.0 50.1 53.1 Age, years 49.5 ± 11.3 49.0 ± 11.3 48.4 ± 11.1 49.9 ± 11.3 50.1 ± 11.5 BMI, kg/m2 22.9 ± 3.3 22.4 ± 3.2 23.0 ± 3.3 22.9 ± 3.3 23.1 ± 3.3 Han ethnicity, % 93.5 91.3 95.6 95.3 95.9 Married, % 93.3 92.8 93.0 93.7 92.9 Urban, % 43.2 43.1 51.1 44.5 36.4 North, % 59.2 51.2 63.5 65.0 73.5 Educational attainment, % Illiteracy 22.4 25.4 15.8 19.0 21.8 1–6 years 26.3 26.2 22.1 26.3 29.0 7–12 years 46.1 44.6 52.6 48.2 46.4 > 12 years 5.2 3.8 9.5 6.5 2.7 Employment status, % Current 55.3 55.0 59.8 53.7 56.1 Former 28.6 27.8 27.3 30.9 28.3 Never 16.1 17.2 12.8 15.5 15.6 Annual household income, % Low 28.8 30.6 23.8 27.1 28.9 Medium 43.4 42.1 45.0 43.6 46.0 High 27.8 27.3 31.2 29.4 25.1 Physical activity, % 0 min/week 75.6 80.2 64.2 70.9 75.1 1–150 min/week 23.9 19.4 34.9 28.6 24.1 > 150 min/week 0.5 0.4 0.9 0.5 0.8 Smoking status, % Yes 39.0 38.1 33.9 39.5 44.8 No 60.9 61.9 66.1 60.5 55.2 Alcohol consumption, % Yes 22.8 21.3 21.5 23.4 27.4 No 77.2 78.7 78.6 76.6 72.7 Sleep duration, % < 6 hours/night 18.5 12.0 12.9 20.0 40.0 6 to 8 hours/night 56.1 57.3 59.2 59.4 45.0 ≥ 8 hours/night 25.4 30.8 27.9 20.6 15.0 Note. Data are presented using mean ± SD for continuous variables and percentages for categorical variables. BMI, body mass index; CVD, cardiovascular disease; HTN, hypertension. Table 2. Effects of daytime napping on cardiovascular disease
Diseases Groups Age- and gender-adjusted model Multivariate modela HR (95% CI) P value P for trend HR (95% CI) P value P for trend CVD < 0.001 < 0.001 0 min 1 (Ref) 1 (Ref) < 30 min 1.17 (0.98 to 1.40) 0.087 1.07 (0.89 to 1.29) 0.448 30 to 60 min 1.29 (1.14 to 1.46) < 0.001 1.22 (1.08 to 1.39) 0.002 ≥ 60 min 1.36 (1.18 to 1.57) < 0.001 1.27 (1.09 to 1.47) 0.002 HTN < 0.001 < 0.001 0 min 1 (Ref) 1 (Ref) < 30 min 1.12 (0.90 to 1.40) 0.308 1.04 (0.83 to 1.30) 0.752 30 to 60 min 1.29 (1.12 to 1.50) 0.001 1.21 (1.04 to 1.41) 0.012 ≥ 60 min 1.48 (1.25 to 1.75) < 0.001 1.38 (1.16 to 1.65) < 0.001 Stroke 0.140 0.137 0 min 1 (Ref) 1 (Ref) < 30 min 0.89 (0.61 to 1.30) 0.544 0.96 (0.65 to 1.42) 0.845 30 to 60 min 1.39 (1.11 to 1.75) 0.004 1.39 (1.10 to 1.76) 0.006 ≥ 60 min 1.07 (0.80 to 1.43) 0.625 1.04 (0.77 to 1.40) 0.602 Note. aWe adjusted gender, age, BMI, ethnicity, marital status, residential region, geolocation, educational attainment, employment status, annual household income, physical activity, smoking status, alcohol consumption, and sleep duration. HR, hazard ratio; 95% CI, 95% confidence interval. Table 3. Subgroup analysis for the association of nap duration with cardiovascular disease
Subgroup Hazard ratioa (95% CI) P for trend P for interaction < 30 min 30 to 60 min ≥ 60 min Gender 0.640 Male (n = 6,676) 1.03 (0.75 to 1.41) 1.20 (0.98 to 1.46) 1.38 (1.11 to 1.73)** 0.003 Female (n = 7,030) 1.09 (0.87 to 1.37) 1.25 (1.06 to 1.48)** 1.21 (0.98 to 1.49) 0.010 Age, years 0.539 30–49 (n = 7,411) 1.11 (0.80 to 1.55) 1.36 (1.08 to 1.73)** 1.23 (0.91 to 1.65) 0.028 ≥ 50 (n = 6,295) 1.08 (0.86 to 1.35) 1.17 (1.01 to 1.37)* 1.31 (1.10 to 1.56)** 0.001 BMI, kg/m² 0.382 < 24 (n = 9,449) 1.22 (0.96 to 1.57) 1.30 (1.10 to 1.54)** 1.32 (1.08 to 1.62)** 0.001 ≥ 24 (n = 4,257) 0.97 (0.74 to 1.29) 1.15 (0.95 to 1.40) 1.24 (0.99 to 1.55) 0.036 Residential region 0.191 Urban (n = 5,914) 1.00 (0.78 to 1.29) 1.08 (0.90 to 1.30) 1.09 (0.87 to 1.38) 0.344 Rural (n = 7,792) 1.17 (0.89 to 1.53) 1.34 (1.12 to 1.60)** 1.41 (1.15 to 1.72)** < 0.001 Geolocation 0.043 North (n = 8,120) 1.06 (0.84 to 1.34) 1.30 (1.11 to 1.53)** 1.33 (1.11 to 1.60)** < 0.001 South (n = 5,586) 1.11 (0.81 to 1.51) 1.09 (0.88 to 1.35) 1.14 (0.86 to 1.51) 0.283 Physical activity 0.189 Yes (n = 3,345) 1.10 (0.82 to 1.46) 1.11 (0.89 to 1.39) 1.01 (0.76 to 1.34) 0.642 No (n = 10,361) 1.03 (0.80 to 1.32) 1.26 (1.07 to 1.47)** 1.38 (1.16 to 1.65)*** < 0.001 Smoking status 0.790 Yes (n = 5,356) 1.02 (0.71 to 1.46) 1.34 (1.08 to 1.67)* 1.42 (1.12 to 1.81)** 0.001 No (n = 8,350) 1.10 (0.89 to 1.37) 1.18 (1.01 to 1.38)* 1.20 (0.99 to 1.46) 0.020 Alcohol consumption 0.007 Yes (n = 3,121) 1.29 (0.86 to 1.92) 1.11 (0.83 to 1.47) 1.46 (1.08 to 1.97)* 0.031 No (n = 10,585) 1.02 (0.83 to 1.26) 1.26 (1.09 to 1.45)** 1.18 (0.99 to 1.43) 0.001 Sleep duration, hours/night 0.168 < 7 (n = 5,599) 0.96 (0.69 to 1.33) 1.17 (0.96 to 1.42) 1.22 (0.97 to 1.52) 0.357 ≥ 7 (n = 8,072) 1.13 (0.90 to 1.42) 1.30 (1.09 to 1.55)** 1.30 (1.05 to 1.61)** 0.001 Note. aWe adjusted gender, age, BMI, ethnicity, marital status, residential region, educational attainment, employment status, annual household income, physical activity, smo, king status, alcohol consumption, and sleep duration. 95% CI, 95% confidence interval. *P < 0.05; **P < 0.01; ***P < 0.001. Table 4. Subgroup analysis for the association of nap duration with hypertension
Subgroup Hazard ratioa (95% CI) P for trend P for interaction < 30 min 30 to < 60 min ≥ 60 min Gender 0.670 Male (n = 6,676) 0.87 (0.60 to 1.28) 1.18 (0.94 to 1.48) 1.42 (1.11 to 1.83)*** 0.006 Female (n =7,030) 1.12 (0.84 to 1.49) 1.24 (1.01 to 1.52)** 1.36 (1.06 to 1.73)** 0.006 Age, years 0.092 30–49 (n = 7,411) 1.13 (0.76 to 1.69) 1.45 (1.09 to 1.92)*** 1.46 (1.03 to 2.05)** 0.006 ≥ 50 (n = 6,295) 1.01 (0.77 to 1.33) 1.13 (0.95 to 1.35) 1.38 (1.13 to 1.69)*** 0.003 BMI, kg/m² 0.396 < 24 (n = 9,449) 1.18 (0.87 to 1.61) 1.26 (1.02 to 1.55)** 1.46 (1.14 to 1.85)*** 0.001 ≥ 24 (n = 4,257) 0.95 (0.68 to 1.31) 1.20 (0.97 to 1.50) 1.38 (1.07 to 1.77)** 0.008 Residential region 0.244 Urban (n = 5,914) 1.08 (0.80 to 1.44) 1.06 (0.85 to 1.31) 1.20 (0.92 to 1.57) 0.230 Rural (n = 7,792) 0.97 (0.68 to 1.39) 1.37 (1.10 to 169)*** 1.52 (1.20 to 1.92)**** < 0.001 Geolocation 0.027 North (n = 8,120) 1.10 (0.82 to 1.47) 1.36 (1.11 to 1.66)*** 1.58 (1.26 to 1.97)**** < 0.001 South (n = 5,586) 1.99 (0.69 to 1.41) 1.08 (0.85 to 1.36) 1.15 (0.84 to 1.55) 0.351 Physical activity 0.040 Yes (n = 3,345) 1.14 (0.82 to 1.58) 1.06 (0.81 to 1.38) 1.01 (0.73 to 1.41) 0.824 No (n=10,361) 0.91 (0.66 to 1.24) 1.27 (1.06 to 1.53)** 1.57 (1.28 to 1.93)**** < 0.001 Smoking status 0.538 Yes (n = 5,356) 0.84 (0.53 to 1.33) 1.34 (1.04 to 1.73)** 1.50 (1.14 to 1.99)*** 0.002 No (n = 8,350) 1.11 (0.86 to 1.44) 1.15 (0.95 to 1.39) 1.32 (1.05 to 1.65)** 0.015 Alcohol consumption 0.272 Yes (n = 3,121) 1.25 (0.78 to 2.01) 1.23 (0.89 to 1.70) 1.56 (1.11 to 2.20)** 0.016 No (n = 10,585) 0.98 (0.76 to 1.27) 1.21 (1.02 to 1.43)** 1.34 (1.09 to 1.64)*** 0.004 Sleep duration, hours/night 0.370 < 7 (n = 5,599) 0.86 (0.57 to 1.29) 1.13 (0.90 to 1.43) 1.34 (1.04 to 1.72)** 0.023 ≥ 7 (n = 8,072) 1.11 (0.85 to 1.46) 1.31 (1.06 to 1.62)** 1.41 (1.10 to 1.79)*** 0.001 Note. aWe adjusted gender, age, BMI, ethnicity, marital status, residential region, educational attainment, employment status, annual household income, physical activity, smoking status, alcohol consumption, and sleep duration. 95% CI, 95% confidence interval. *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001. S2. Sensitive analysis of hazard ratios (95% CIs) for incident CVDs associated with napping duration, by excluding those who developed outcomes in 1 year after baseline survey, study participants aged > 75 years and participants who had changed daytime-napping behaviors during follow-ups
Diseases Groups HR (95% CI) Main model Model 1 Model 2 Model 3 CVD < 30 min 1.07 (0.89, 1.29) 1.10 (0.92, 1.33) 1.10 (0.91, 1.33) 1.25 (1.03, 1.51)* 30 to 60 min 1.22 (1.08, 1.39)** 1.23 (1.09, 1.40)** 1.25 (1.10, 1.42)** 1.38 (1.20, 1.57)*** ≥ 60 min 1.27 (1.09, 1.47)** 1.28 (1.11, 1.48)*** 1.33 (1.15, 1.54)*** 1.42 (1.22, 1.66)*** HTN < 30 min 1.04 (0.83, 1.30) 1.04 (0.83, 1.30) 1.05 (0.84, 1.31) 1.14 (0.90, 1.45) 30 to 60 min 1.21 (1.04, 1.41)* 1.22 (1.05, 1.42)** 1.23 (1.06, 1.44)** 1.36 (1.16, 1.60)*** ≥ 60 min 1.38 (1.16, 1.65)*** 1.41 (1.19, 1.67)*** 1.44 (1.12, 1.71)*** 1.57 (1.31, 1.88)*** Stroke < 30 min 0.96 (0.65, 1.42) 1.01 (0.69, 1.49) 1.04 (0.71, 1.54) 1.06 (0.70, 1.59) 30 to 60 min 1.39 (1.10, 1.76)** 1.40 (1.11, 1.77)** 1.43 (1.13, 1.81)** 1.52 (1.19, 1.95)*** ≥ 60 min 1.04 (0.77, 1.40) 1.06 (0.79, 1.42) 1.09 (0.81, 1.47) 1.14 (0.84, 1.55) Note. Abbreviations: HR, hazard ratio; CI, confidence interval; CVDs, cardiovascular diseases; HTN, hypertension. Model 1: restricting our study outcomes beyond the initial first year. Model 2: restricting participants aged < 75 years. Model 3: restricting the analysis to adults who had not changed daytime-napping behaviors during follow-ups. *P < 0.05, **P < 0.01, ***P < 0.001. S1. Subgroup analysis for the association of nap duration with stroke
Subgroup Hazard ratioa (95% CI) P for trend P for interaction < 30 min 30 to 60 min ≥ 60 min Gender 0.339 Male (n = 6,676) 0.81 (0.42 to 1.58) 1.36 (0.96 to 1.91) 1.17 (0.78 to 1.75) 0.183 Female (n = 7,030) 1.08 (0.67 to 1.75) 1.39 (1.01 to 1.93)* 0.86 (0.54 to 1.37) 0.549 Age, years 0.815 30–49 (n = 7,411) 0.67 (0.26 to 1.71) 1.20 (0.70 to 2.04) 0.75 (0.36 to 1.54) 0.810 ≥ 50 (n = 6,295) 1.07 (0.70 to 1.64) 1.43 (1.10 to 1.86)** 1.13 (0.81 to 1.58) 0.077 BMI, kg/m2 0.464 < 24 (n = 9,449) 0.71 (0.41 to 1.22) 1.39 (1.06 to 1.84)* 0.91 (0.63 to 1.33) 0.417 ≥ 24 (n = 4,257) 1.47 (0.82 to 2.61) 1.30 (0.84 to 2.02) 1.30 (0.77 to 2.19) 0.227 Residential region 0.351 Urban (n = 5,914) 0.88 (0.49 to 1.57) 1.18 (0.81 to 1.73) 0.99 (0.59 to 1.67) 0.653 Rural (n = 7,792) 1.05 (0.62 to 1.77) 1.59 (1.17 to 2.16)** 1.09 (0.75 to 1.59) 0.108 Geolocation < 0.001 North (n = 8,120) 0.94 (0.60 to 1.46) 1.32 (1.00 to 1.74)* 0.89 (0.63 to 1.26) 0.695 South (n = 5,586) 0.95 (0.43 to 2.13) 1.33 (0.84 to 2.13) 1.44 (0.78 to 2.65) 0.139 Physical activity 0.787 Yes (n = 3,345) 0.84 (0.42 to 1.69) 1.51 (0.98 to 2.33) 0.81 (0.42 to 1.53) 0.570 No (n = 10,361) 1.07 (0.67 to 1.71) 1.31 (0.98 to 1.73) 1.08 (0.77 to 1.52) 0.240 Smoking status 0.380 Yes (n = 5,356) 0.73 (0.33 to 1.61) 1.61 (1.11 to 2.34)* 1.19 (0.76 to 1.86) 0.104 No (n = 8,350) 1.08 (0.69 to 1.69) 1.29 (0.95 to 1.75) 0.91 (0.60 to 1.38) 0.602 Alcohol consumption 0.751 Yes (n = 3,121) 0.69 (0.24 to 1.97) 1.31 (0.79 to 2.17) 1.12 (0.64 to 1.99) 0.449 No (n = 10,585) 1.04 (0.68 to 1.58) 1.43 (1.10 to 1.86)** 1.02 (0.71 to 1.45) 0.165 Sleep duration, hours/night 0.364 < 7 (n = 5,599) 0.70 (0.36 to 1.37) 0.97 (0.69 to 1.37) 0.84 (0.55 to 1.26) 0.528 ≥ 7 (n = 8,072) 1.12 (0.69 to 1.80) 1.86 (1.35 to 2.57)*** 1.20 (0.78 to 1.86) 0.012 Note. aWe adjusted gender, age, BMI, ethnicity, marital status, residential region, educational attainment, employment status, annual household income, physical activity, smoking status, alcohol consumption, and sleep duration. 95% CI, 95% confidence interval. *P < 0.05; **P < 0.01; ***P < 0.001. -
[1] Sacco RL, Roth GA, Reddy KS, et al. The heart of 25 by 25: achieving the goal of reducing global and regional premature deaths from cardiovascular diseases and stroke: a modeling study from the american heart association and world heart federation. Circulation, 2016; 133, e674−90. [2] Liu SW, Li YC, Zeng XY, et al. Burden of cardiovascular diseases in China, 1990-2016: findings from the 2016 global burden of disease study. JAMA Cardiol, 2019; 4, 342−52. doi: 10.1001/jamacardio.2019.0295 [3] Mills KT, Bundy JD, Kelly TN, et al. Global disparities of hypertension prevalence and control: a systematic analysis of population-based studies from 90 countries. Circulation, 2016; 134, 441−50. doi: 10.1161/CIRCULATIONAHA.115.018912 [4] Kearney PM, Whelton M, Reynolds K, et al. Global burden of hypertension: analysis of worldwide data. Lancet, 2005; 365, 217−23. doi: 10.1016/S0140-6736(05)17741-1 [5] Ezzati M, Obermeyer Z, Tzoulaki I, et al. Contributions of risk factors and medical care to cardiovascular mortality trends. Nat Rev Cardiol, 2015; 12, 508−30. doi: 10.1038/nrcardio.2015.82 [6] James PA, Oparil S, Carter BL, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA, 2014; 311, 507−20. doi: 10.1001/jama.2013.284427 [7] Cappuccio FP, Miller MA. Sleep and cardio-metabolic disease. Curr Cardiol Rep, 2017; 19, 110. doi: 10.1007/s11886-017-0916-0 [8] Covassin N, Singh P. Sleep duration and cardiovascular disease risk: epidemiologic and experimental evidence. Sleep Med Clin, 2016; 11, 81−9. doi: 10.1016/j.jsmc.2015.10.007 [9] Huang TY, Mariani S, Redline S. Sleep irregularity and risk of cardiovascular events: the multi-ethnic study of atherosclerosis. J Am Coll Cardiol, 2020; 75, 991−9. [10] Milner CE, Cote KA. Benefits of napping in healthy adults: impact of nap length, time of day, age, and experience with napping. J Sleep Res, 2009; 18, 272−81. doi: 10.1111/j.1365-2869.2008.00718.x [11] Wang CS, Bangdiwala SI, Rangarajan S, et al. Association of estimated sleep duration and naps with mortality and cardiovascular events: a study of 116 632 people from 21 countries. Eur Heart J, 2019; 40, 1620−9. doi: 10.1093/eurheartj/ehy695 [12] Cao ZQ, Shen LJ, Wu J, et al. The effects of midday nap duration on the risk of hypertension in a middle-aged and older Chinese population: a preliminary evidence from the Tongji-Dongfeng Cohort Study, China. J Hypertens, 2014; 32, 1993−8. doi: 10.1097/HJH.0000000000000291 [13] Fang WM, Li ZL, Wu L, et al. Longer habitual afternoon napping is associated with a higher risk for impaired fasting plasma glucose and diabetes mellitus in older adults: results from the Dongfeng-Tongji cohort of retired workers. Sleep Med, 2013; 14, 950−4. doi: 10.1016/j.sleep.2013.04.015 [14] Yang LL, Xu ZG, He MA, et al. Sleep duration and midday napping with 5-year incidence and reversion of metabolic syndrome in middle-aged and older Chinese. Sleep, 2016; 39, 1911−8. [15] Cairns BJ, Travis RC, Wang XS, et al. A short-term increase in cancer risk associated with daytime napping is likely to reflect pre-clinical disease: prospective cohort study. Br J Cancer, 2012; 107, 527−30. doi: 10.1038/bjc.2012.291 [16] Zhong GC, Wang Y, Tao TH, et al. Daytime napping and mortality from all causes, cardiovascular disease, and cancer: a meta-analysis of prospective cohort studies. Sleep Med, 2015; 16, 811−9. doi: 10.1016/j.sleep.2015.01.025 [17] Tanabe N, Iso H, Seki N, et al. Daytime napping and mortality, with a special reference to cardiovascular disease: the JACC study. Int J Epidemiol, 2010; 39, 233−43. doi: 10.1093/ije/dyp327 [18] Newman AB, Spiekerman CF, Enright P, et al. Daytime sleepiness predicts mortality and cardiovascular disease in older adults. J Am Geriatr Soc, 2000; 48, 115−23. doi: 10.1111/j.1532-5415.2000.tb03901.x [19] Bursztyn M, Ginsberg G, Hammerman-Rozenberg R, et al. The siesta in the elderly: risk factor for mortality? Arch Intern Med, 1999; 159, 1582-6. [20] Stang A, Dragano N, Moebus S, et al. Midday naps and the risk of coronary artery disease: results of the heinz nixdorf recall study. Sleep, 2012; 35, 1705−12. doi: 10.5665/sleep.2248 [21] Häusler N, Haba-Rubio J, Heinzer R, et al. Association of napping with incident cardiovascular events in a prospective cohort study. Heart, 2019; 105, 1793−8. doi: 10.1136/heartjnl-2019-314999 [22] Naska A, Oikonomou E, Trichopoulou A, et al. Siesta in healthy adults and coronary mortality in the general population. Arch Intern Med, 2007; 167, 296−301. doi: 10.1001/archinte.167.3.296 [23] Blachier M, Dauvilliers Y, Jaussent I, et al. Excessive daytime sleepiness and vascular events: the three city study. Ann Neurol, 2012; 71, 661−7. doi: 10.1002/ana.22656 [24] Gangwisch JE, Rexrode K, Forman JP, et al. Daytime sleepiness and risk of coronary heart disease and stroke: results from the Nurses' Health Study II. Sleep Med, 2014; 15, 782−8. doi: 10.1016/j.sleep.2014.04.001 [25] Leng Y, Wainwright NWJ, Cappuccio FP, et al. Daytime napping and the risk of all-cause and cause-specific mortality: a 13-year follow-up of a British population. Am J Epidemiol, 2014; 179, 1115−24. doi: 10.1093/aje/kwu036 [26] Zhou L, Yu K, Yang LL, et al. Sleep duration, midday napping, and sleep quality and incident stroke: the Dongfeng-Tongji cohort. Neurology, 2020; 94, e345−56. doi: 10.1212/WNL.0000000000008739 [27] Yang YH, Liu W, Ji XP, et al. Extended afternoon naps are associated with hypertension in women but not in men. Heart Lung, 2020; 49, 2−9. doi: 10.1016/j.hrtlng.2019.09.002 [28] Wu L, He Y, Jiang B, et al. Association between sleep duration and the prevalence of hypertension in an elderly rural population of China. Sleep Med, 2016; 27−28,92-8. [29] Xie Y, Hu JW. An introduction to the China family panel studies (CFPS). Chin Sociol Rev, 2014; 47, 3−29. [30] Xie Y, Lu P. The sampling design of the China family panel studies (CFPS). Chin J Sociol, 2015; 1, 471−84. doi: 10.1177/2057150X15614535 [31] Tamaki M, Shirota A, Hayashi M, et al. Restorative effects of a short afternoon nap (<30 min) in the elderly on subjective mood, performance and eeg activity. Sleep Res Online, 2000; 3, 131−9. [32] Yan MM, Fu Z, Qin TT, et al. Associations of sleep duration and prediabetes prevalence in a middle-aged and elderly Chinese population with regard to age and hypertension: The China Health and Retirement Longitudinal Study baseline survey. J Diabetes, 2018; 10, 847−56. [33] Kehoe R, Wu SY, Leske MC, et al. Comparing self-reported and physician-reported medical history. Am J Epidemiol, 1994; 139, 813−8. doi: 10.1093/oxfordjournals.aje.a117078 [34] Chen C, Lu FC. The guidelines for prevention and control of overweight and obesity in Chinese adults. Biomed Environ Sci, 2004; 17 Suppl, 1-36. [35] Okely AD, Kontsevaya A, Ng J, et al. 2020 WHO guidelines on physical activity and sedentary behavior. Sports Med Health Sci, 2021; 3, 115−8. doi: 10.1016/j.smhs.2021.05.001 [36] Zhou T, Cheng G, Wu XH, et al. The associations between sleep duration, academic pressure, and depressive symptoms among chinese adolescents: results from china family panel studies. Int J Environ Res Public Health, 2021; 18, 6134. doi: 10.3390/ijerph18116134 [37] Zhou JM, Kessler AS, Su DJ. Association between daytime napping and chronic diseases in China. Am J Health Behav, 2016; 40, 182−93. doi: 10.5993/AJHB.40.2.3 [38] Watkins JF. Reviewed Work: modelling survival data in medical research. by D. Collett. J Roy Stat Soc, 1995; 44, 281−2. [39] Annesi I, Moreau T, Lellouch J. Efficiency of the logistic regression and Cox proportional hazards models in longitudinal studies. Stat Med, 1989; 8, 1515−21. doi: 10.1002/sim.4780081211 [40] Coorperative Meta-Analysis Group of Working Group On Obesity in China. Prospective study for cut-off points of body mass index in Chinese adults. Chin J Epidemiol, 2002; 23, 431−4. (In Chinese [41] Watson NF, Badr MS, Belenky G, et al. Joint consensus statement of the american academy of sleep medicine and sleep research society on the recommended amount of sleep for a healthy adult: methodology and discussion. Sleep, 2015; 38, 1161−83. doi: 10.5665/sleep.4886 [42] Zhang ZY, Xiao XL, Ma WX, et al. Napping in older adults: a review of current literature. Curr Sleep Med Rep, 2020; 6, 129−35. doi: 10.1007/s40675-020-00183-x [43] Liu XK, Zhang Q, Shang XM. Meta-analysis of self-reported daytime napping and risk of cardiovascular or all-cause mortality. Med Sci Monit, 2015; 21, 1269−75. doi: 10.12659/MSM.893186 [44] Yan B, Li JM, Li RH, et al. Association of daytime napping with incident cardiovascular disease in a community-based population. Sleep Med, 2019; 57, 128−34. doi: 10.1016/j.sleep.2019.02.014 [45] Yamada T, Hara K, Shojima N, et al. Daytime napping and the risk of cardiovascular disease and all-cause mortality: a prospective study and dose-response meta-analysis. Sleep, 2015; 38, 1945−53. doi: 10.5665/sleep.5246 [46] Yang LL, Yang HD, He MA, et al. Longer sleep duration and midday napping are associated with a higher risk of CHD incidence in middle-aged and older Chinese: the Dongfeng-Tongji cohort study. Sleep, 2016; 39, 645−52. doi: 10.5665/sleep.5544 [47] Schwartz J, Allison MA, Ancoli-Israel S, et al. Sleep, type 2 diabetes, dyslipidemia, and hypertension in elderly Alzheimer's caregivers. Arch Gerontol Geriatr, 2013; 57, 70−7. doi: 10.1016/j.archger.2013.02.008 [48] Cheungpasitporn W, Thongprayoon C, Srivali N, et al. The effects of napping on the risk of hypertension: a systematic review and meta-analysis. J Evid Based Med, 2016; 9, 205−12. doi: 10.1111/jebm.12211 [49] Wannamethee SG, Papacosta O, Lennon L, et al. Self-reported sleep duration, napping, and incident heart failure: prospective associations in the british regional heart study. J Am Geriatr Soc, 2016; 64, 1845−50. doi: 10.1111/jgs.14255 [50] Hays JC, Blazer DG, Foley DJ. Risk of napping: excessive daytime sleepiness and mortality in an older community population. J Am Geriatr Soc, 1996; 44, 693−8. doi: 10.1111/j.1532-5415.1996.tb01834.x [51] Chooi YC, Ding C, Magkos F. The epidemiology of obesity. Metabolism, 2019; 92, 6−10. doi: 10.1016/j.metabol.2018.09.005 [52] Ren Q, Su C, Wang HJ, et al. Change in body mass index and its impact on incidence of hypertension in 18-65-year-old Chinese adults. Int J Environ Res Public Health, 2016; 13, 257. doi: 10.3390/ijerph13030257 [53] Ford ES, Wheaton AG, Chapman DP, et al. Associations between self-reported sleep duration and sleeping disorder with concentrations of fasting and 2-h glucose, insulin, and glycosylated hemoglobin among adults without diagnosed diabetes. J Diabetes, 2014; 6, 338−50. doi: 10.1111/1753-0407.12101 [54] Liu RH, Li YQ, Wang F, et al. Age- and gender-specific associations of napping duration with type 2 diabetes mellitus in a Chinese rural population: the RuralDiab study. Sleep Med, 2017; 33, 119−24. doi: 10.1016/j.sleep.2016.09.004 [55] Huang M, Yang YP, Huang ZJ, et al. The association of nighttime sleep duration and daytime napping duration with hypertension in Chinese rural areas: a population-based study. J Hum Hypertens, 2021; 35, 896−902. doi: 10.1038/s41371-020-00419-x [56] Li X, Pang XY, Liu ZP, et al. Joint effect of less than 1 h of daytime napping and seven to 8 h of night sleep on the risk of stroke. Sleep Med, 2018; 52, 180−7. doi: 10.1016/j.sleep.2018.05.011 [57] Bursztyn M. Mortality and the siesta, fact and fiction. Sleep Med, 2013; 14, 3−4. doi: 10.1016/j.sleep.2012.09.010 [58] Kario K. Morning surge in blood pressure and cardiovascular risk. Hypertension, 2010; 56, 765−73. doi: 10.1161/HYPERTENSIONAHA.110.157149 [59] Hoshide S, Cheng HM, Huang QF, et al. Role of ambulatory blood pressure monitoring for the management of hypertension in Asian populations. J Clin Hypertens, 2017; 19, 1240−5. doi: 10.1111/jch.13086 [60] Mantua J, Spencer RMC. Exploring the nap paradox: are mid-day sleep bouts a friend or foe? Sleep Med, 2017; 37, 88-97. [61] Dowd JB, Goldman N, Weinstein M. Sleep duration, sleep quality, and biomarkers of inflammation in a Taiwanese population. Ann Epidemiol, 2011; 21, 799−806. doi: 10.1016/j.annepidem.2011.07.004 [62] Ardern CI, Kanagasabai T. Sleep, abdominal obesity, and metabolic syndrome. In: Watson RR. Nutrition in the Prevention and Treatment of Abdominal Obesity. Elsevier. 2019, 3-18. [63] Grandner MA, Jackson N, Gerstner JR, et al. Dietary nutrients associated with short and long sleep duration. Data from a nationally representative sample. Appetite, 2013; 64, 71−80. [64] Angermann CE, Ertl G. Depression, anxiety, and cognitive impairment: comorbid mental health disorders in heart failure. Curr Heart Fail Rep, 2018; 15, 398−410. doi: 10.1007/s11897-018-0414-8 [65] Bertisch SM, Pollock BD, Mittleman MA, et al. Insomnia with objective short sleep duration and risk of incident cardiovascular disease and all-cause mortality: sleep heart health study. Sleep, 2018; 41, zsy047.